Adjusted EBITDAloss for the three months ended September 30, 2025, was $1.82 million, compared to a loss of $0.23 million in Q3 2024. For the nine months ended September 30, 2025, Adjusted EBITDA loss ...
In the Phase III results presented and published today, olezarsen demonstrated rapid, substantial and significant reductions in triglycerides by up to 72% on top of standard of care and reduced the ...
This quarter introduced new opportunities while reinforcing the broadening appeal of some of our mainstay technologies,” said P. Peter Pascali, President and CEO of PyroGenesis Inc. “The $1.2 million ...
What happens to psychoanalysis when the individual mind disappears? Here's a critique of the concept of the "analytic third." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback